Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational study.

Saved in:
Bibliographic Details
Title: Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational study.
Authors: Takahashi H; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Kurashiki, Okayama, 710-8602, Japan. ht16523@kchnet.or.jp., Arita M; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Kurashiki, Okayama, 710-8602, Japan., Sato R; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Kurashiki, Okayama, 710-8602, Japan., Amano A; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Kurashiki, Okayama, 710-8602, Japan., Hamakawa M; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Kurashiki, Okayama, 710-8602, Japan., Ishida T; Department of Respiratory Medicine, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Kurashiki, Okayama, 710-8602, Japan., Tachibana H; Department of Respiratory Medicine, National Hospital Organization Minami Kyoto Hospital, 11, Ashihara, Naka, Joyo-city, Kyoto, 610-0113, Japan.
Source: BMC pulmonary medicine [BMC Pulm Med] 2026 May 12; Vol. 26 (1). Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first